Measles Outbreak in Indonesia

THE spread of measles has again become a specter. Up to April 2026, the disease resulting from Morbillivirus infection has affected 39 regencies and cities in 14 provinces. Almost 9,000 people have earned a suspect status and a number of cases have ended in death. This is not a mere surge in the total of cases, but rather also a sign of failure in preventing an outbreak that should have be avoidable.

The government has declared public health emergencies 59 times across 39 regions in the past three months. A situation like this should not have occurred if there had been early anticipation. Moreover, the alarm had already been ringing loudly since measles cases surged in several regions in 2025. In Sumenep Regency, East Java, for instance, 20 children died and nearly 3,000 people were declared to be suspected cases.

Since the Sumenep cases emerged, epidemiologists had warned the government about the risk of a surge in cases in 2026. However, those warnings were not followed by adequate policy corrections. The same pattern has repeated: the government identifies outbreak risks early but does not move swiftly to anticipate them.

In a modern approach of public health, prevention should be in the front line. An epidemic like measles should not be dealt with as it is spreading, but it should instead be prevented before transmission occurs.

In this framework, the key to measles control is basically already clear: a minimum immunization coverage of 95 percent in order to develop herd immunity. But the target has never been consistently achieved. When there is inter-regional immunization coverage disparity, the virus will always find loopholes to spread more extensively.

Amid these conditions, doubts have emerged about the effectiveness of vaccines, as measles cases have also occurred among individuals who have been immunized. This interpretation is mistaken. At the population level, vaccines reduce transmission, not provide absolute protection. When immunization coverage does not reach a safe threshold, cases will still appear—and will disproportionately affect those who are not protected.

Therefore, when measles resurges, the government cannot simplify the issue by blaming groups that refuse vaccines. Such a stance instead obscures the main problem: the failure to ensure equitable immunization coverage and to build public trust.

The more fundamental problem lies in the consistency and prioritization of policy. The fiscal policy that reduces support for basic health service has a direct impact on the vaccination coverage. Incentives for field personnel are shrinking, regional administrations’ actions are limited, and front-line capacities are weakening. Under such conditions, the return of an epidemic is only a matter of time.

The experience of various countries in facing Covid-19 has shown that the epidemic was thriving when health authorities were slow to act. With all its limitations, Indonesia was indeed capable of ensuring Covid-19 vaccination. Yet when its resources were focused on overcoming the pandemic, the prevention of other diseases like measles was just weakening.

Guidelines from the World Health Organization (WHO) emphasize that measles can be prevented through high and evenly distributed immunization coverage, as well as rapid responses to every infection case. These standards are clear and have repeatedly proven effective. When measles outbreaks continue to recur, the problem is not a lack of knowledge, but rather policy priorities.